Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Ventyx Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 63 | 104 | +41 |
| Shares | 34.6M | 39.3M | +4.66M (+13.5%) |
| Value | $423.5M | $1.37B | +$947.3M (+223.7%) |
New holders (44)
Institutions that held Ventyx Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (3)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 206,400 | $2.52M |
| UBS Group AG | 2,052 | $25.0K |
| Captrust Financial Advisors | 36 | $0 |